Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain

By Tassain V.   Attal N.   Fletcher D.   Brasseur L.   Degieux P.   Chauvin M.   Bouhassira D.  

Pain, Vol. 104, Iss. 1, 2003-07 ,pp. : 389-400

Elsevier

Access to resources Recommend Favorite

Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

By Candiotti Keith A.   Gitlin Melvin C.  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1677-1684

Informa Healthcare

Access to resources Recommend Favorite

Interprofessional education in chronic non-cancer pain

By Allen Michael   Macleod Tanya   Zwicker Beverley   Chiarot Marco   Critchley Carol  

Journal of Interprofessional Care, Vol. 25, Iss. 3, 2011-05 ,pp. : 221-222

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

By Clark A.J.   Ahmedzai S.H.   Allan L.G.   Camacho F.   Horbay G.L.A.   Richarz U.   Simpson K.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1419-1428

Informa Healthcare

Access to resources Recommend Favorite

Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study

By Blake Sue   Ruel Brian   Seamark Clare   Seamark David  

British Journal of General Practice, Vol. 57, Iss. 535, 2007-02 ,pp. : 101-108

Royal College of General Practitioners

Access to resources Recommend Favorite